Sitagliptin-associated drug reaction with eosinophilia and systemic symptoms (dress): a case report

• In: Posters: Hospital Pharmacy Section
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POS-HPS022
• By: YU, Jarlee (ChangGung Memorial Hospital, Taipei, Pharmacy, Taipei, China Taiwan)
• Co-author(s): Cheng, Chi-Yuan (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
  Chung, Wen-Hung (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
  Tsai, Tzu-Cheng (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
  Chen, Wei-Li (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
  Deng, Shin-Tarng (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
  
• Abstract:

  Sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, was approved for the treatment of type 2 diabetes mellitus (DM). Hypersensitivity reactions have been reported during post-marketing surveillance of sitagliptin. We report a rare case of sitagliptin-associated drug reaction with eosinophilia and systemic symptoms (DRESS). This was a case of..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login